1 Doran, T. et al. «Effect of financial incentives on inequalities in the delivery of primary clinical care in England: analysis of clinical activity indicators for the quality and outcomes framework», Lancet, Vol. 372 (2008), 728–36.
2 Payne, Rupert A. «The epidemiology of polypharmacy». Clinical Medicine 16, no. 5 (2016): 465–9.
3 Reeve, E. et al. «Review of deprescribing process and development of an evidence-based, patient-centered deprescribing process». British Journal of Clinical Pharmacology 78, no. 4 (2014): 738–47.
4 Reeve, E. et al. «Feasibility of a Patient-Centered Deprescribing Process to Reduce Inappropriate Use of Proton Pump Inhibitors». The Annals of Pharmacotherapy 49, no. 1 (2015): 29–38.
5 Schiff, G. et al. «Incorporating Indications into Medication Ordering – Time to Enter the Age of Reason». The New England Journal of Medicine 375, no. 4 (2016): 306–9.
6 Schwappach, D. et al. «Threats to patient safety in the primary care office: concerns of physicians and nurses». Swiss Medical Weekly 142, no. w.13601 (2012).